Laura Alaimo

Excited to share our recent work on robot-assisted liver resection using the Versius® surgical system. 👉The first clinical series demonstrating the feasibility and short-term safety of this platform 👉Detailed analysis of surgical workflow and costs.

It was an honour and a pleasure for us to host Professor Manuel Maglione from Innsbruck! A valuable opportunity to share knowledge and "tips and tricks" in HPB, robotic and minimally invasive surgery, and a multidisciplinary approach to liver diseases. Thanks, Manuel! Tschuss!

We are delighted to endorse the 5th International Expert Meeting on Cholangiocarcinoma taking place 19-20 February 2026 in Verona, Italy ✨ There is still time to secure you place! More information available here ➡️ organizing.it/event/ecm-chol…

It's that time of the year! We are proud to share the program of our yearly Robotic HPB Surgery course, which reached its fifth edition! 🧑‍⚕️A panel of experts from different centers, 🤖daVinci simulator, 🐷hands-on wet lab with our own Porcine Liver Model Don't miss it!

🤖 It was a pleasure to host the 𝟐𝐧𝐝 𝐌𝐚𝐬𝐭𝐞𝐫𝐜𝐥𝐚𝐬𝐬 𝐑𝐨𝐛𝐨𝐭𝐢𝐜 𝐋𝐢𝐯𝐞𝐫 𝐒𝐮𝐫𝐠𝐞𝐫𝐲 this week in Ulm with a fantastic group of surgeons from 5 countries. 🙏 Many thanks to all participants, sponsors and my team! 🗓️3rd Masterclass to take place from 13-14 Oct.

Incredibly grateful to ILLS2025 in Seoul! 👉Unforgettable experience both scientifically & personally 👉Extraordinary surgeons to meet 👉True honored to receive the Travel Grant and present some of the scientific work from @HPBVerona @ARuzzenente Thank you @ILLS_LAPLIVER !

🚀 Updates on the management of neuroendocrine liver metastasis (NELM) 👉 Latest insights on diagnosis, surgery, systemic therapy, and future directions! 🔗 oaepublish.com/articles/2394-… #NeuroendocrineTumors #LiverMetastasis #Oncology #CancerResearch #Hepatology

🚨 Excited to share @OhioStateSurg latest paper! 🔎Can machine learning help assess MILS complexity for HCC? 📋Tumor, surgical, and patient factors all play a role 🎯More complex surgery = ⬆️complication risk ➡️ Read more: authors.elsevier.com/c/1kmOW,V2cWJd… @timpawlik @OSUWexMed

🚨 New publication alert! 📊 What's the best method to evaluate surgical care quality? 🎯 The mDOOR was associated with survival and outperformed other traditional metrics. ➡️ Check it out: authors.elsevier.com/sd/article/S13… Thankful to Dr.@timpawlik and @OhioStateSurg TEAM❗@OSUWexMed

Check out @OhioStateSurg TEAM's latest in @JournalofGISurg! ⚠️1 in 3 patients developed recurrence after GBC surgery 🫁Patients with lung recurrence had the longest survival ✨ML can identify patients with favourable survival More👉authors.elsevier.com/sd/article/S10… @timpawlik @OSUWexMed

Laparoscopic Sg8 Segmentectomy with cranio-caudal approach: is it the “new” standard tecniques or just a passing trend?

A very nice meeting was held yesterday in Verona between high level surgeons but above all between friends from Tirol, Südtirol, Trentino, Veneto and Lombardy with a Guest Star from Tübingen

#AudioVisualAbstract : Benchmarks in #LiverResection for Intrahepatic #Cholangiocarcinoma @LauraAlaimo5 @timpawlik @YutakaEndoSurg @ARuzzenente @skmaithel @ItaruEndo rdcu.be/dZWAZ @BotelhoDra @SyedAAhmad5

Bittersweet visit to @UniVerona DoS 🇮🇹 to participate in the dedication of a conference room in the name of my dear friend and former research fellow Fabio Bagante. You continue to live through the legacy of friendships that endure in all of us 🙏 #neverforgetyou

How to predict the risk of early recurrence in peri-hilar cholangiocarcinoma? Try the Preoperative Recurrence Score!!!🕵️ 4 easy-to-asses features: 1️⃣ size >18mm 2️⃣ suspected LN 3️⃣ HA involvement 4️⃣ PV involvement 🇮🇹 Cohort & 2 🇳🇱🇻🇦Validation Cohorts 👉 authors.elsevier.com/a/1jvwj2gGSo76…

Warm welcome to our new #BMCSurg Editorial Board Members @SavvasLampridis and @LauraAlaimo5. We are looking forward to working with you. Interested in joining #BMCSurg? To find out more visit <bmcsurg.biomedcentral.com/join-our-edito…>

🔢How many subtypes of intrahepatic cholangiocarcinoma do you know? 👩‍🔬Multi-omics analyses help answer the question. 🥼What about the clinical characteristics? Check out the Systematic Review from our team at @HPBVerona @ARuzzenente 🔎mdpi.com/2072-6694/16/1…

Proud to share our new article! 📝 comprehensive review of a rapidly evolving topic 💪🏻 pCR with TNT ‼️should we change our standard? @ARuzzenente @GOstuzzi @UniVerona @JAMANetworkOpen

New paper from @timpawlik group🚨 #AI synthesizes vast data for decision support, uses ML & NLP for insights, enhances real-time surgical navigation, and improves #hepatobiliary cancer care #AIinHealthcare more info: oaepublish.com/articles/ais.2… @LauraAlaimo5

Portal stenting in recurrent or locally advanced pCCA! - Safe & Feasible (💯% success rate!, 13% overall complications) 💪 - Improves QoL 🆙 and allows patients to get Chemo! 💊 Check out our paper on EJSO DOI: 10.1016/j.ejso.2024.107984 @UniVerona #HPB #liversurgery #pcca